Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshihide Shirota is active.

Publication


Featured researches published by Toshihide Shirota.


Diabetes Care | 1988

Hypouricemia in NIDDM Patients

Masaki Ishihara; Toshio Shinoda; Toru Aizawa; Toshihide Shirota; Yoshitaka Nagasawa; Takashi Yamada

I n the epidemiological survey conducted by Herman et al. (1), serum uric acid levels were significantly lower in non-insulin-dependent diabetic (NIDDM) patients than in normal subjects. Gotfredsen et al. (2) also reported a decrease in serum uric acid levels in insulin-dependent diabetic patients, and increases in urinary uric acid excretion and uric acid clearance (Curate). In this study, we investigated the serum and urinary uric acid levels in NIDDM patients and discuss the mechanism of hypouricemia in diabetic patients. Two hundred and four nonnephrotic NIDDM patients (95 men, 109 women) and 44 normal controls (20 men, 24 women) were studied. All participants were admitted to the hospital between January 1984 and September 1987. Diagnosis of diabetes was based on the 1982 Japan Diabetes Society criteria (3). Patients with >25 mg/dl of proteinuria in morning urine samples, measured with a Combistix (Ames-Sankyo, Tokyo), were excluded from the study. Patients whose insulin dosage was >0.6 U/kg of body weight and who were receiving diuretics, antigout or antituberculous agents, antibiotics, aspirin, or anti-inflammatory agents were also excluded. Forty-nine of the diabetic patients were treated with insulin with the mean dosage consisting of 22.7 U/day. Forty-five patients received oral hypoglycemics, and the remainder were treated by diet therapy. Ageand body-weight-matched subjects with no major diseases were used as control subjects. Medical problems were either thyroid adenoma or simple goiter with normal thyroid function. Diabetic patients maintained their prescribed diets containing 25-30 kcal/kg of ideal body weight with 17% protein, 23% fat, and 60% carbohydrate. Control subjects maintained a normal hospital diet containing 2200 kcal/day with the same composition of protein, fat, and carbohydrate as diabetic patients. Blood and urine samples were collected at 0800 after at least 10 h of fasting. A 2-h postprandial plasma glucose level was measured at 1030. In 100 of the diabetic patients (49 men, 51 women) and all the controls, urine samples were collected for 3 days after the blood sampling day. From the 3-day measurements, the average data per 24 h were used for analysis. Serum and urinary uric acid levels were measured by a colorimetric procedure using an enzymatic (uricase) method, and plasma and urinary glucose levels were measured by the glucose oxidase method. Other serum chemicals were analyzed by an autoanalyzer (SMAC, Technicon Japan, Tokyo). Table 1 shows 13 clinical parameters in NIDDM patients and controls. Diabetic patients had a signifi-


Diabetes Research and Clinical Practice | 1992

Abnormal molecular weight profile of urinary protein in rats with streptozotocin-induced diabetes

Naomi Okada; Toru Aizawa; Nakako Yokokawa; Mutsuhiro Kobayashi; Tatsumi Moriya; Satoshi Shigematsu; Toshihide Shirota; Mitsuhisa Komatsu; Toshio Shinoda; Takashi Yamada; Koh Nakazawa; Nobuo Itoh; Hidekazu Shigematsu

A quantitative analysis of the molecular weight (MW) profile of urinary protein by SDS-PAGE was performed in streptozotocin (STZ)-injected, non-ketotic diabetic rats (DM group), diabetic rats receiving dipyridamole (DM-DIP group), normal rats (C group) and STZ-injected rats with near-normal glycemia due to insulin treatment (DM-INSULIN group). In the DM group, decrease of a small MW protein (SMWP) (MW 19.5 k) was found at 2.5 weeks, and an increase of larger MW proteins (LMWP) (MW 68 [albumin], 55 and 29 k) together with a decrease of SMWPs (MW 19.5 and 15 k) was found at 15 weeks, as compared to the C group: the MW profile of urinary protein in the DM-INSULIN and C groups was indistinguishable. At 15 weeks, creatinine clearance (Ccr) was significantly depressed and an increase in the mesangial matrix with electron dense deposits was evident in the DM group. The urinary protein abnormalities were partially corrected and the reduction of Ccr was absent in the DM-DIP group with no effect on glomerular morphology. STZ-induced diabetes in rats is accompanied by a reduction of urinary SMWP, and a subsequent increase of LMWP and depression of Ccr: dipyridamole ameliorates urinary protein abnormalities and prevents the reduction of Ccr.


Angiology | 1988

Partial resection of atrial septal aneurysm with multiple fenestrations: a case report

Teruki Kondo; Tsutomu Iwasaki; Kunihide Hiramatsu; Masafumi Katakura; Toshihide Shirota; Takashi Yamada; Hiromichi Miwa; Yukio Fukaya; Masami Morimoto; Futoshi Iida

Aneurysms of the interatrial septum are uncommon lesions that are often accompanied by other cardiac anomalies or systemic thrombosis. The authors report 1 case of atrial septum aneurysm that was diagnosed by two-dimensional contrast echocardiography. At surgery a membrane-like, fenestrated aneurys mal protrusion to the right atrium without thrombosis was seen. The atrial septum was closed without using an artificial patch after some of the aneurysm with fenestrations was resected.


Metabolism-clinical and Experimental | 1992

Alteration of renal function in hyperthyroidism : increased tubular secretion of creatinine and decreased distal tubule delivery of chloride

Toshihide Shirota; Toshio Shinoda; Takashi Yamada; Toru Aizawa


Artificial Organs | 1990

Usefulness of Thrombelastography for Dosage Monitoring of Low Molecular Weight Heparin and Unfractionated Heparin During Hemodialysis

Toshio Shinoda; Hideo Arakura; Masafumi Katakura; Toshihide Shirota; Seinosuke Nakagawa


Clinical Nephrology | 1990

Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus.

Toshio Shinoda; M. Ishihara; F. Kurimoto; Toru Aizawa; Kunihide Hiramatsu; Toshihide Shirota; Nobuyuki Takasu; Takashi Yamada


Clinical Nephrology | 1989

Intestinal pseudo-obstruction due to dialysis amyloidosis.

Toshio Shinoda; Mitsuhisa Komatsu; Toru Aizawa; Toshihide Shirota; Takashi Yamada; Ehara T; Mizukami E


Clinical Nephrology | 1992

Primary hypothyroidism and multiple endocrine failure in association with hemochromatosis in a long-term hemodialysis patient.

Toshihide Shirota; Toshio Shinoda; Toru Aizawa; Mizukami T; Masafumi Katakura; Nobuyuki Takasu; Takashi Yamada


Metabolism-clinical and Experimental | 1995

Hyperuricemia in patients with hyperthyroidism due to graves' disease

Akira Sato; Toshihide Shirota; Toshio Shinoda; Ichiro Komiya; Toru Aizawa; Yoshihro Takemura; Takashi Yamada


Nephron | 1992

Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient

Toshio Shinoda; Tom Aizawa; Toshihide Shirota; Masafumi Katakura; Takashi Yamada; Hideo Arakura; Yu Tai Chang; Shinya Kobayashi; Tetsutaro Mizukami

Collaboration


Dive into the Toshihide Shirota's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nobuyuki Takasu

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Seinosuke Nakagawa

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge